Deal activity in healthcare private equity surged during 2024, with transaction values reaching their second-highest level ever recorded, according to Bain & Company’s Global Healthcare Private Equity Report. For J-P Conte, a managing partner with decades of experience in the sector, this momentum demonstrates fundamental shifts in how capital transforms healthcare delivery.
“I think to be a businessperson, you need to be optimistic,” Conte says. “To be a business builder, you need to be optimistic about the future, and you need to know you can have an impact on things by sheer hard work or thinking about things differently.”
J-P Conte’s approach to healthcare investments centers on sector specialization rather than opportunistic deal-making. His career at a San Francisco-based private equity firm focused on four core areas: healthcare, financial services, software, and industrial technology. This concentrated strategy allows investors to develop genuine expertise in market dynamics, regulatory environments, and operational challenges specific to each sector.
The Healthcare Technology Transformation
Healthcare technology has emerged as a particularly active investment area. Revenue cycle management systems represent one of the fastest-growing segments, with U.S. market valuations exceeding $172 billion in 2024 and annual expansion rates above 10% projected through the decade’s end. J-P Conte’s experience includes investments in clinical trial technology and healthcare data solutions—areas where operational transformation can generate substantial value.
Consider the example of combining CRF Health with Bracket to form Signant Health in 2018. Conte remarked that this combination would “create a world-class healthcare technology company” supporting clinical trials globally. Healthcare technology deals accounted for nearly one-third of all healthcare investment in the first half of 2025, driven by administrative automation and AI-enabled solutions.
Operational Value Creation Over Financial Engineering
The healthcare investment environment has fundamentally changed from the leverage-driven transactions of previous decades. Mid-market healthcare private equity firms have consistently outperformed larger funds by focusing on operational improvements rather than financial engineering alone. J-P Conte’s investment philosophy emphasizes this hands-on approach to building businesses.
Healthcare organizations face mounting cost pressures from labor shortages and rising supply expenses. Private equity investors see opportunities to leverage economies of scale and improved operational efficiencies to reduce overhead while increasing profitability. This requires deep industry knowledge and the ability to implement meaningful improvements across portfolio companies.
Conte’s experience spans multiple healthcare subsectors, from clinical research organizations to healthcare technology platforms. When his firm acquired eResearch Technology in 2012, the investment involved multiple add-on acquisitions and operational enhancements over several years, transforming ERT into a comprehensive platform for clinical trial data collection. Conte attributed the successful outcome to the ability to “drive change in a sector in which we have deep industry expertise,” combined with recruiting exceptional management talent.
Complex Market Dynamics and Regulatory Challenges
Healthcare private equity faces unprecedented scrutiny from regulators. Massachusetts recently passed amendments expanding reporting requirements, creating new licensing mandates, and expressly granting the ability to hold private equity investors liable for False Claims Act violations. Multiple states are considering similar legislation, making regulatory navigation a foundational issue in healthcare transactions.
Despite these headwinds, certain healthcare subsectors remain particularly attractive. Infusion services benefit from multiple tailwinds: the disproportionately high number of infusion specialty drugs in the FDA approval pipeline, an aging population with chronic needs, and pressure from payors to move patients out of hospital-based centers. The sector remains highly fragmented with relatively light regulation, creating opportunities for consolidation and value creation through professional management practices.
The Data Revolution in Healthcare Investment
Healthcare investment decisions increasingly rely on sophisticated data analysis rather than intuition. Nearly half of all hospitals and health systems have adopted artificial intelligence within their revenue cycle operations, while global markets for AI-enabled revenue cycle management solutions are expected to expand sevenfold by decade’s end. J-P Conte’s investments in healthcare technology positioned his portfolio companies to capitalize on this transformation toward data-driven operations.
Revenue cycle management technology exemplifies how healthcare operations can benefit from automation. Autonomous coding systems can automatically generate medical codes from electronic documentation, alleviating administrative burden while improving accuracy and compliance. Healthcare providers implementing these solutions report measurable results: one health system reduced annual coding costs by $500,000, decreased accounts receivable by 50%, and increased charge capture by 10% after implementing autonomous coding.
Private equity firms increasingly focus on assets that improve operational efficiencies for providers, including technology that optimizes revenue cycle management workflows, software that enhances workforce management, and AI automation technology. This trend aligns with J-P Conte’s emphasis on using deep industry knowledge to effect meaningful improvements at portfolio companies.
Building Human Capital Through Mentorship
Beyond financial returns, Conte emphasizes the importance of developing talent within portfolio companies and the broader investment community. “There isn’t a single skill that will make you successful,” he noted when discussing career advice. “Showing up and executing, even when it is hard,” coupled with genuine enthusiasm for the work, are essential traits for long-term success in the industry.
His approach extends to mentoring young professionals and students through internship programs and educational initiatives. This commitment to human capital development demonstrates a broader understanding that successful healthcare investments require not just financial resources but also skilled teams capable of executing operational improvements.
Healthcare private equity in 2025 demands more than capital deployment. Investors like J-P Conte who combine sector expertise, operational focus, and commitment to building organizations rather than simply buying and selling assets are positioned to create sustainable value. With healthcare spending continuing to grow and technology enabling new efficiencies, the sector offers substantial opportunities for those prepared to invest the time and expertise required to drive genuine transformation.
Click here to learn more about J-P Conte.
Pallavi Singal is the Vice President of Content at ztudium, where she leads innovative content strategies and oversees the development of high-impact editorial initiatives. With a strong background in digital media and a passion for storytelling, Pallavi plays a pivotal role in scaling the content operations for ztudium’s platforms, including Businessabc, Citiesabc, and IntelligentHQ, Wisdomia.ai, MStores, and many others. Her expertise spans content creation, SEO, and digital marketing, driving engagement and growth across multiple channels. Pallavi’s work is characterised by a keen insight into emerging trends in business, technologies like AI, blockchain, metaverse and others, and society, making her a trusted voice in the industry.
